Last reviewed · How we verify

NCT05318261: WIPO

Incidence and Risk Factors of Weaning-induced Cardiac Dysfunction: Results From a Multicenter, Observational Study

Completed Last updated 16 November 2022
What this trial tests

trial testing Spontaneous breathing trial in Weaning Failure in 500 participants. Completed in 3 June 2022.

Timeline
1 July 2019
Primary endpoint
28 February 2021
3 June 2022

Quick facts

Lead sponsorBicetre Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment500
Start date1 July 2019
Primary completion28 February 2021
Estimated completion3 June 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Bicetre Hospital

Who can join

18 and older, any sex, with Weaning Failure or Weaning-induced Pulmonary Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During weaning from mechanical ventilation, the shift from positive to negative pressure ventilation may be responsible for a cardiac dysfunction that can lead to the development of pulmonary oedema (weaning-induced pulmonary oedema, WIPO) and to the failure of spontaneous breathing trials. However, the incidence and risk factors for WIPO development are not well defined and have been investigated only by a few studies.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Incidence and risk factors of weaning-induced pulmonary oedema: results from a multicentre, observational study.
    Shi R, Ayed S, Beuzelin M, Persichini R, et al · · 2025 · cited 4× · PMID 40165223 · DOI 10.1186/s13054-025-05350-6

Verify or expand the search:

Other trials of Spontaneous breathing trial

Trials testing the same drug.

Other recruiting trials for Weaning Failure

Currently open trials in the same condition.

Other Bicetre Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318261.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing